Catalogo dei prodotti della ricerca

DE SANTIS, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.337
EU - Europa 4.517
AS - Asia 792
AF - Africa 51
SA - Sud America 46
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.251
IT - Italia 3.325
IN - India 330
SE - Svezia 315
SG - Singapore 235
UA - Ucraina 207
FI - Finlandia 183
CN - Cina 181
DE - Germania 136
GB - Regno Unito 85
CA - Canada 65
FR - Francia 51
IE - Irlanda 46
BG - Bulgaria 41
AR - Argentina 36
AT - Austria 20
NL - Olanda 20
TG - Togo 20
BE - Belgio 19
BJ - Benin 18
CH - Svizzera 16
RO - Romania 15
MX - Messico 11
MY - Malesia 9
IR - Iran 8
TR - Turchia 8
BZ - Belize 7
PK - Pakistan 7
PT - Portogallo 7
AL - Albania 5
BR - Brasile 5
PL - Polonia 5
RU - Federazione Russa 5
HK - Hong Kong 4
KR - Corea 4
SC - Seychelles 4
AU - Australia 3
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
DZ - Algeria 2
ES - Italia 2
RS - Serbia 2
SI - Slovenia 2
VN - Vietnam 2
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
GH - Ghana 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 11.747
Salva come PNG Salva come JPEG
Città #
Fairfield 1.079
Woodbridge 562
Rome 546
Chandler 496
Ashburn 441
Seattle 383
Houston 367
Wilmington 356
Cambridge 328
Ann Arbor 258
Princeton 209
Milan 184
Plano 154
Dearborn 146
San Paolo di Civitate 115
Singapore 107
Lawrence 93
Millbury 91
Beijing 87
Jacksonville 83
Florence 77
Palermo 77
Boston 68
Naples 68
San Diego 67
Turin 63
Andover 59
Des Moines 49
Fremont 47
Ottawa 46
Dublin 45
Catania 44
Helsinki 43
Bari 36
Bologna 36
Bremen 36
Federal 36
Sofia 35
New York 33
Norwalk 31
Pisa 31
Falls Church 29
Genoa 26
Lucca 25
San Jose 25
Brescia 24
Boardman 23
Frankfurt am Main 22
Livorno 22
Perugia 22
Southend 21
Lomé 20
Verona 20
Brussels 19
Vienna 19
San Mateo 18
Cagliari 17
Fasano 17
Bühl 15
Dallas 15
Toronto 15
Camden 14
Caserta 14
Padova 14
Reggio Emilia 13
Monza 12
Auburn Hills 11
Formigine 11
Kunming 11
Nanjing 11
Bergamo 10
Los Angeles 10
Arezzo 9
Hefei 9
Mannheim 9
Pescara 9
Salerno 9
Altopascio 8
Cascina 8
Empoli 8
Iesi 8
Lamezia Terme 8
Latina 8
Parma 8
Belize City 7
Grezzana 7
Kuala Lumpur 7
Legnano 7
London 7
Mascalucia 7
Mumbai 7
Nanchang 7
Napoli 7
Phoenix 7
Prato 7
Ragusa 7
Sassari 7
Sesto San Giovanni 7
Torino 7
Altamura 6
Totale 7.869
Salva come PNG Salva come JPEG
Nome #
Ridotta prevalenza di “skip areas” nel fegato steatosico in pazienti con calcolosi multipla della colecisti ed in soggetti colecistectomizzati 2.185
FISIOLOGIA DEL FEGATO E METABOLISMO ENERGETICO 730
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 158
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 115
Diagnostic imaging for hepatocellular carcinoma 102
Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: A pilot study 98
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis 98
Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control 95
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors 95
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? 94
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 93
Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis. 89
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 88
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease 86
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement 86
Application of acoustic radiation force impulse elastography in non invasive diagnosis of focal nodular hyperplasia 86
The human gut microbiota and virome: potential therapeutic implications 85
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy. 84
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 84
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis 84
HAMP GENE MUTATION C.208T>C (P.C70R) IDENTIFIED IN AN ITALIAN PATIENT WITH SEVERE HEREDITARY HEMOCHROMATOSIS. 83
The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC) 83
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 81
Nutritional habits in patients with chronic liver disease: adherence of real life diet to international guidelines and its association with disease stage 79
ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY" (ARFI) ASSESSMENT OF FOCAL NODULAR HYPERPLASIA: PRELIMINARY RESULTS 78
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 78
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 77
Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis 76
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 76
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection 75
Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results 75
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 74
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C 74
Management of refractory typical GERD symptoms 74
Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients 73
Ultrasonography in the study of hepatocellular carcinoma in woodchucks chronically infected with WHV 73
Clinical Manifestations of gallstone disease: evidence from the Multicenter Italian study on Cholelithiasis (MICOL) 72
The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt 72
Clinical course, management, and platelet activity assessment of splanchnic VITT: a case report 72
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease 71
Hepatic steatosis after liver transplantation: Prevalence and associated factors 70
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. 70
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 69
ARFI Elastometry Assessment of Focal Nodular Hyperplasia: Preliminary Results 69
Expression of estrogen receptors in cholangiocytes of patients with primary biliary cirrhosis (PBC) and relationship with immunohistochemical markers of cell proliferation and death 68
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. 68
Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein 67
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis. A real-life study 67
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 67
Kinetic characterisation in needle biopsies of hepatocellular carcinama: feasibility and preliminari results. 66
Bile acid metabolism in liver disease 66
Epidemiology of gallstone disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 66
Biliary Secretion of Phosphatidylcholine and its molecular species in cholecystectomized T - Tube patients: Effects of bile acid hydrophilicity. 66
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging 65
Diet and gallstones in Italy: The cross-sectional MICOL results 64
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 64
Prevalence of gallstone disease in an Italian adult female population. 63
Beta adrenergic receptors in the parathyroid glands. 63
Gallstones and diabetes: a case - control study in a free - living population sample. 62
Epidemiologia della colelitiasi in Italia . Esperienze del GREPCO: Gruppo Romano per l'Epidemiologia e la Prevenzione della Colelitiasi 62
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis 62
Prevalenced of portal vein thrombosis (PVT) and associated factors in cirrhotic patients 62
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 61
Increased resting energy expenditure in patients with hepato cellular carcinoma 61
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B. 60
Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. 60
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 59
Clinical symptoms and gallstone disease: lessons from a population study 59
The natural history of gallstones: the GREPCO experience 59
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts 58
Incidence and natural history of small esophageal varices in cirrhotic patients 57
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody 57
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients 57
Biliary sludge: a critical update. 56
PRESENTATION OF THE RIFLE PROJECT RISK-FACTORS AND LIFE EXPECTANCY 56
Cost analysis for the prevention of variceal rebleeding in cirrhotic patients: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy 56
Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings 55
Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case-control study 55
Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib? 55
Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis. 55
Effect of a medium dose of Ursodeoxycholic acid with or without Taurine supplementation on the nutritional status of patients with Cystic fibrosis:A randomized, placebo-controlled,crossover trial 54
Cholelithiasis and blood groups: evidence for a lack of association 54
null 54
Etiology, management, and outcome of the Budd-Chiari syndrome. 54
Sterile abscesses complicating monoclonal gammopathy of undetermined significance. 54
Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis 53
The GREPCO research programmes: aims and prevalence data. 52
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis 52
Dermatologic lesions in patients with chronic hepatitis C treated with alfs interferon alone or in combination with ribavirin and with or without amantadine 51
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma 51
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study 51
TREATMENT WITH INTERFERON (IFN) PLUS RIBAVIRIN (RBV) OF β-THALASSEMIC PATIENTS WITH HCV CHRONIC HEPATITIS 51
null 51
Factors associated with gallstone disease: observations in the GREPCO Study 50
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 50
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy 49
Role of Octreoscan in advanced hepatocellular carcinoma 48
The diabetes-cholelithiasis association in case-control study 48
Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report 48
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease 48
Totale 9.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.942 0 94 23 101 217 408 297 261 235 151 87 68
2020/2021947 101 95 54 112 42 63 19 79 77 199 71 35
2021/20221.967 37 79 167 56 259 72 65 213 166 158 312 383
2022/20232.706 408 376 117 295 269 259 142 179 245 123 165 128
2023/20242.272 134 188 170 198 206 239 224 206 51 238 189 229
2024/2025250 218 32 0 0 0 0 0 0 0 0 0 0
Totale 12.034